Anti-Venom Market: Region, Key Players, Competition and Forecast to 2023

Pune, India, 5th December 2018: MarketResearchFuture announced addition of new report, titled “Anti-Venom Market Research Report – Forecast to 2023”.

Pune, India - December 5, 2018 /MarketersMedia/ —

Market Highlights
Anti-venom is a purified antibody used against venoms or venom components. In this process, animals are immunized with the venom of a snake, and then antibodies are extracted from it. Anti-venom is the only definitive treatment against snake or scorpion bites.

Several factors such as the increasing cases of snake bites, increasing government funding, increasing patient pool, unmet medical needs, increasing awareness about antivenoms, and enhancing regulatory framework are boosting the growth of the market.
However, high costs of available anti-venoms, strict FDA regulations, difficult preparation of anti-venoms, and poor healthcare system in low- and middle-income countries may hamper the growth of the market over the forecast period.
It is estimated that the anti-venom market is expected to grow at a CAGR of 6.5% during the forecast period of 2017–2023.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/5859
Regional Analysis
The Americas dominates the anti-venom market owing to the increasing cases of snake bites, and scorpion bites and high healthcare expenditure.
Europe holds the second position in the anti-venom market. The financial support by the government towards research and development and improvement in the reimbursement scenario are expected to drive the European anti-venom market. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014 i.e. EUR 321 billion which is further followed by France with EUR 237 billion and the United Kingdom with EUR 223 billion. In 2016, the R&D expenditure in the pharmaceutical industry was EUR 35000 million, suggested by the European Federation of Pharmaceutical Industries and Association.
Asia Pacific is the fastest growing anti-venom market owing to a huge patient pool and rising advancements in pharmaceuticals. According to the Indian Brand Equity Foundation (IBEF), in 2016 the generics market of India stood at USD 26.1 billion. As per the statistics suggested by the World Health Organization (WHO), it has been estimated that around 2.8 million people are bitten by snakes and nearly 46 900 people die from snakebite every year.
The Middle East and Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.
Segmentation
The global anti-venom market is segmented by type, type of species, mode of action, product type, and end-user.
On the basis of type, the global anti-venom market is classified as polyvalent heterologous antivenom, monovalent heterologous antivenom, homologous antivenom, and small molecule anti-toxins.
On the basis of type of species, the global anti-venom market is classified as snakes, scorpions, spider, and others. The snake segment is further classified as common cobra, common krait, Russell viper, and others.
On the basis of mode of action, the global anti-venom market is classified as cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic, and others.
On the basis of product type, the global anti-venom market is classified as snake anti-venom, scorpion anti-venom, spider anti-venom, others.
On the basis of end-user, the global anti-venom market is segmented into hospitals, clinics, ambulatory surgical centers, and others.
Key Players
Some of the key players in the global anti-venom market are Allison Medical, Inc., Artsana S.p.a., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Hamilton Company, Hill-Rom, Hu-Friedy Mfg. Co., LLC, Johnson & Johnson Services, Inc, Medline Industries, Inc., Medtronic plc, Novo Nordisk A/s, Owen Mumford, Ltd., Roboz Surgical Instrument, Smiths Medical, Stryker Corporation, Terumo Corporation, Thermo Fisher Scientific, UltiMed, Inc., Ypsomed Holding AG, and others.

Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Anti-Venom Market, By Type
Chapter 7. Global Anti-Venom Market, By Type Of Species
Chapter 8. Global Anti-Venom Market, By Mode Of Action

Access Report Details @ https://www.marketresearchfuture.com/reports/anti-venom-market-5859

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar,
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com

Source URL: https://marketersmedia.com/anti-venom-market-region-key-players-competition-and-forecast-to-2023/455243

Source: MarketersMedia

Release ID: 455243